Hormone Therapy May Protect Transgender Patients From Depression

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 18, 2025.

By I. Edwards HealthDay Reporter

TUESDAY, March 18, 2025 -- Gender-affirming hormone therapy may not only help transgender and nonbinary individuals physically -- it could also improve their mental health, new research suggests.

A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were prescribed hormone therapy had a 15% lower risk of moderate to severe depression over four years compared to those who did not receive hormones.

“Trans people experience mental health disparities with higher rates of depression and suicidality than cisgender (non-transgender) people,” lead study author Sari Reisner, associate professor of epidemiology at University of Michigan School of Public Health, told CNN. “Trans people are literally dying. There is an urgent need -- now more than ever -- to care for us, support us, and ensure we have the life-saving care that we deserve and need to thrive.”

The researchers analyzed data from 3,592 patients at two federally qualified community health centers in Boston and New York.

They compared patients' hormone therapy prescriptions with their scores on the Patient Health Questionnaire, which measures depression levels.

Those who received hormone therapy had significantly lower risks of moderate to severe depression during their follow-ups.

“Providing gender hormones did not just provide physical benefits to transgender and gender diverse patients, but yet again, we demonstrate that they improve their mental health outcomes as well,” said Dr. Michelle Forcier, medical director for FOLX Health, a mental health and wellness telehealth platform for people in the LGBTQIA+ community.

Mental health disparities among transgender people are a serious public health concern.

While the National Institute of Mental Health reports that about 8.3% of U.S. adults experience major depression, a 2023 study found that about 33% of transgender individuals report symptoms of depression.

Systemic problems, including stigma, attacks on civil rights and preventing access to health care, add to mental health challenges, Melina Wald, a clinical psychologist in private practice in Connecticut and New York state, told CNN via email.

Legislation targeting transgender health care has been on the rise. In 2018, Reisner noted, two bills were introduced, compared to 185 bills in 2023.

“Recent Executive Orders banning ‘gender ideology’ and restricting the rights of trans people have devastating mental health consequences for trans communities,” she explained.

Experts said the study’s diverse sample -- including patients of different ages, races and socioeconomic backgrounds -- makes the findings especially valuable.

“That these patients benefited from care in these various primary care clinics in a diversity of communities suggests that effective gender affirmative hormone is no longer restricted to urban, academic, specialty clinics,” Forcier said.

Overall, research underscores the safety and benefits of hormone therapy.

“We have more than 25 years of consistent, persistent, insistent evidence that gender affirmative approaches to care for transgender persons offer a variety of medical and mental health benefits," Forcier said. "There are no studies that suggest that withholding medically indicated, safe, effective care (offers) any benefit at all.”

Sources

  • CNN, March 17, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-03-19 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords